ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 632,71
0,00%
Dow Jones
40 211,72
0,53%
DAX
18 600,18
0,00%
Brent Oil
83,715
-0,74%
Bitcoin
63 278,93
-2,43%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Hutchison China Meditech Ltd (0J7G)

  7. Hutchison China Meditech Ltd (0J7G) Actualités

0J7G

Hutchison China Meditech (0J7G)

Hutchison China Meditech Ltd
De:
Trier par:
 Showing the most relevant articles for your search:LSE:0J7G
DateHeureSourceTitreSymboleSociété
03/12/202108h00UK RegulatoryHutchmed (China) Limited Updated NRDL to include ELUNATE and SULANDALSE:0J7GHutchison China Meditech Ltd
30/11/202109h29UK RegulatoryHutchmed (China) Limited Total Voting RightsLSE:0J7GHutchison China Meditech Ltd
24/11/202108h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED and AZ Initiate SACHI Phase 3 TrialLSE:0J7GHutchison China Meditech Ltd
08/11/202108h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED to Present Clinical Data at ASHLSE:0J7GHutchison China Meditech Ltd
01/11/202108h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED and AZ Initiate SAMETA Global P3 TrialLSE:0J7GHutchison China Meditech Ltd
28/10/202108h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Initiates Phase III Trial of HMPL-523LSE:0J7GHutchison China Meditech Ltd
20/10/202110h30UK RegulatoryHutchmed (China) Limited Grant of Awards under Long Term Incentive PlanLSE:0J7GHutchison China Meditech Ltd
29/09/202108h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Highlights Presentations at CSCO 2021LSE:0J7GHutchison China Meditech Ltd
29/09/202108h00RNS Non-RegulatoryHutchmed (China) Limited Closure of Non-Core OTC Joint Venture DivestmentLSE:0J7GHutchison China Meditech Ltd
21/09/202108h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Initiates Phase III Trial SURTORI-01LSE:0J7GHutchison China Meditech Ltd
20/09/202108h00RNS Non-RegulatoryHutchmed (China) Limited Japan Bridging Study For Surufatinib InitiatedLSE:0J7GHutchison China Meditech Ltd
13/09/202108h00RNS Non-RegulatoryHutchmed (China) Limited Breakthrough Therapy Designation for AmdizalisibLSE:0J7GHutchison China Meditech Ltd
08/09/202112h30RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED and AZ Initiate Phase III Trial in ChinaLSE:0J7GHutchison China Meditech Ltd
07/09/202110h30RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED to Present Clinical Data at ESMOLSE:0J7GHutchison China Meditech Ltd
06/09/202108h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Shares Included in Stock Connect ProgramsLSE:0J7GHutchison China Meditech Ltd
02/09/202113h45UK RegulatoryHutchmed (China) Limited Grant of Share Options, and Awards under LTIPLSE:0J7GHutchison China Meditech Ltd
26/08/202108h00RNS Non-RegulatoryHutchmed (China) Limited Phase Ib/II Trial of Fruquintinib & TislelizumabLSE:0J7GHutchison China Meditech Ltd
23/08/202108h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Selected for Certain Hang Seng IndexesLSE:0J7GHutchison China Meditech Ltd
17/08/202110h30UK RegulatoryHutchmed (China) Limited ELECTRONIC COMMUNICATION OF CORPORATE INFORMATIONLSE:0J7GHutchison China Meditech Ltd
09/08/202108h00UK RegulatoryHutchmed (China) Limited HUTCHMED & Epizyme Announce TAZVERIK CollaborationLSE:0J7GHutchison China Meditech Ltd
28/07/202113h00UK RegulatoryHutchmed (China) Limited Interim Results and Business UpdatesLSE:0J7GHutchison China Meditech Ltd
28/07/202108h00RNS Non-RegulatoryHutchmed (China) Limited Phase II Trial of ORPATHYS InitiatedLSE:0J7GHutchison China Meditech Ltd
23/07/202113h01UK RegulatoryHutchmed (China) Limited Stabilizing Actions & End of Stabilization PeriodLSE:0J7GHutchison China Meditech Ltd
16/07/202111h50UK RegulatoryHutchmed (China) Limited Holding(s) in CompanyLSE:0J7GHutchison China Meditech Ltd
16/07/202108h00RNS Non-RegulatoryHutchmed (China) Limited Surufatinib MAA Submitted and Validated by the EMALSE:0J7GHutchison China Meditech Ltd
13/07/202108h00RNS Non-RegulatoryHutchmed (China) Limited First Commercial Sale of ORPATHYS(R) in ChinaLSE:0J7GHutchison China Meditech Ltd
12/07/202115h35UK RegulatoryHutchmed (China) Limited Full Exercise of the Over-allotment OptionLSE:0J7GHutchison China Meditech Ltd
06/07/202110h30RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Initiates Phase I Trials of HMPL-295LSE:0J7GHutchison China Meditech Ltd
02/07/202110h30UK RegulatoryHutchmed (China) Limited Notice of ResultsLSE:0J7GHutchison China Meditech Ltd
01/07/202112h00RNS Non-RegulatoryHutchmed (China) Limited US FDA Accepts NDA Filing for SurufatinibLSE:0J7GHutchison China Meditech Ltd
 Showing the most relevant articles for your search:LSE:0J7G

Dernières Valeurs Consultées

BIT
P1R4Z1
BNP Paribas Issuance
BIT
UB82CZ
Unicredit Bank
LSE
0V46
Liberty Gold
BIT
P21CA5
NLBNPIT21CA5 20991231 16...
LSE
0HMP
Bellerophon Therapeutics
LSE
0RQO
Bonesupport Holding Ab
LSE
0D20
Bank Fuer Tirol Und Vora...
LSE
0QPM
Bb Biotech
NASDAQ
SBCF
Seacoast Banking Corpora...
LSE
0LRD
Atlanta Poland
NASDAQ
SVIIR
Spring Valley Acquisitio...
LSE
0LRF
Atm Grupa
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés